Virologist Polly Roy tells Vanita Srivastava why #Sputnik is a good vaccine, the reason for increasing the gap between #Covishield shots, & more.
https://www.moneycontrol.com/news/trends/health-trends/mixing-and-matching-of-two-vaccines-is-not-only-good-but-better-than-taking-either-jab-alone-virologist-professor-polly-roy-6992881.html
https://www.moneycontrol.com/news/trends/health-trends/mixing-and-matching-of-two-vaccines-is-not-only-good-but-better-than-taking-either-jab-alone-virologist-professor-polly-roy-6992881.html
Moneycontrol
Mixing And Matching Of Two Vaccines Is Not Only Good But Better Than Taking Either Jab Alone: Virologist Prof. Polly Roy
London School of Hygiene & Tropical Medicine's Polly Roy on why it's important to vaccinate everyone - rich or homeless - against Covid-19, and why 'vaccination and only vaccination is the way forward'.
#MarketsWithMC | Wockhardt share price rises over 7 % intraday after entering into an agreement with Dubai-based Enso Healthcare, and Human Vaccine LLC for manufacturing and supplying #Sputnik vaccine against #COVID19:
https://www.moneycontrol.com/news/business/markets/wockhardt-share-price-rises-7-on-deal-to-manufacture-sputnik-vaccines-7330791.html?utm_source=telegram&utm_medium=social
https://www.moneycontrol.com/news/business/markets/wockhardt-share-price-rises-7-on-deal-to-manufacture-sputnik-vaccines-7330791.html?utm_source=telegram&utm_medium=social
Moneycontrol
Wockhardt Share Price Rises 7% On Deal To Manufacture Sputnik Vaccines
The company will manufacture and supply up to 620 million doses of the Sputnik V and the Sputnik Light vaccines
#COVID19VaccineUpdate | Dr Reddy's Laboratories has received approval from the drugs regulator to conduct Phase 3 trials of single-dose #COVID19 vaccine #Sputnik Light ⬇
https://www.moneycontrol.com/news/india/dr-reddys-gets-dcgi-nod-to-conduct-phase-3-trial-of-sputnik-light-in-india-7469221.html?utm_source=telegram&utm_medium=social
https://www.moneycontrol.com/news/india/dr-reddys-gets-dcgi-nod-to-conduct-phase-3-trial-of-sputnik-light-in-india-7469221.html?utm_source=telegram&utm_medium=social
Moneycontrol
Dr Reddy's Gets DCGI Nod To Conduct Phase 3 Trial Of Sputnik Light In India
According to RDIF, the single-dose Sputnik Light vaccine demonstrated 79.4 percent efficacy
#DGCI has granted emergency use permission to single-dose #Sputnik Light COVID-19 #vaccine in India, Union Health Minister Dr Mansukh Mandaviya informed.
Read here 👇
https://www.moneycontrol.com/news/coronavirus/covid-19-vaccine-dgci-grants-eua-for-single-dose-sputnik-light-8047111.html?utm_source=telegram&utm_medium=social
Read here 👇
https://www.moneycontrol.com/news/coronavirus/covid-19-vaccine-dgci-grants-eua-for-single-dose-sputnik-light-8047111.html?utm_source=telegram&utm_medium=social
Moneycontrol
COVID-19 Vaccine: DGCI grants EUA for single dose Sputnik Light
Tweeting the news out on February 6, the Health Minister said that this is India's ninth COVID-19 vaccine in the country.